In Vitro Activity of Carbenicillin Against Gram-negative Bacilli
Overview
Authors
Affiliations
The activity of a new semisynthetic penicillin, carbenicillin, was determined against 241 strains of gram-negative bacilli with the tube-dilution technique. Of 143 strains of Pseudomonas sp., 99 had a minimal inhibitory concentration of 200 to 300 mug/ml. The majority of strains of Escherichia coli and Proteus spp. were sensitive to this antibiotic, with minimal inhibitory concentrations of 25 mug/ml or less. Strains of Klebsiella sp. were quite resistant to carbenicillin. The size of inoculum had no significant effect on the minimal inhibitory concentration for Pseudomonas sp.
Human pharmacology of 6-[D-alpha-(3-guanylureido)-phenylacetamido]-penicillanic acid (BL-P1654).
Bodey G, Horikoshi N, Rodriguez V Antimicrob Agents Chemother. 1974; 5(4):366-70.
PMID: 15825389 PMC: 428976. DOI: 10.1128/AAC.5.4.366.
Comparative in vitro evaluation of BL-P1654 and carbenicillin against Pseudomonas.
Overturf G, Ressler R, Wilkins J Antimicrob Agents Chemother. 1974; 6(5):643-6.
PMID: 15825320 PMC: 444707. DOI: 10.1128/AAC.6.5.643.
Susceptibility of Pseudomonas aeruginosa to carbenicillin.
Traub W, RAYMOND E Appl Microbiol. 1970; 20(4):630-2.
PMID: 5498614 PMC: 377005. DOI: 10.1128/am.20.4.630-632.1970.
Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.
Meyer R, Young L, Armstrong D Appl Microbiol. 1971; 22(6):1147-51.
PMID: 5002900 PMC: 376501. DOI: 10.1128/am.22.6.1147-1151.1971.
Phair J, Watanakunakorn C, Bannister T Appl Microbiol. 1969; 18(3):303-6.
PMID: 4984762 PMC: 377973. DOI: 10.1128/am.18.3.303-306.1969.